Alzheimer's drug offers 'tantalising' hope for sufferers
New antibody drug aducanumab could be prescribed as a preventative medicine in the future, say scientists
![dementia.jpg](https://cdn.mos.cms.futurecdn.net/GYMZWeJ6scnHBYeXa3ndDk-415-80.jpg)
A new Alzheimer's drug is being hailed a potential game changer for people with the condition.Patients treated over six months with aducanumab showed an almost complete clearance of the sticky plaques that stop brain cells communicating and which lead to memory loss and cognitive decline.
"We can potentially make a great step forward in treating Alzheimer's disease," said Professor Roger Kitsch, of the University of Zurich.The breakthrough has been hailed as the best news in Alzheimer's research in 25 years and scientists believe the drug "could be the first stepping stone to finding a cure for the, as yet, incurable condition", says the Daily Express.
Aducanumab is likely to be most effective for patients in the earliest stages of the disease or for those who have not yet begun to show symptoms, adds the Daily Telegraph.Dr Al Sandrock, of biotech company Biogen, predicted it could be used for patients with no symptoms of Alzheimer's but with amyloid plaques on the brain. "We do that with cholesterol where people don't have cardiovascular disease," he said, reports the Financial Times. Even healthy pensioners could one day be prescribed the drug to "ward off dementia", says the Daily Mail, "in much the same way as statins are given today to those at risk of heart attacks".
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
However, there are still several hurdles to overcome. "The two biggest barriers to the drug will now be proving that it works across more early-stage patients and dealing with the side-effects," says The Times. Those side-effects include a dangerous swelling of the brain among patients on the highest dose.
Added to that, drugs that seem promising when given to small groups of people can fail spectacularly when tested on large numbers. "Two much larger trials, recruiting 2,700 patients in 20 countries, are needed to confirm whether the tantalising signs of benefit are real," reports The Guardian.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Last hurrah: have standing ovations gone too far?
Talking Point The media loves measuring audience applause but default 'clapathons' are 'running riot through our theatres'
By Chas Newkey-Burden, The Week UK Published
-
'Unspeakable new suffering'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
Engel Ayurpura: a boutique Ayurveda retreat in the Dolomites
The Week Recommends The tranquil Italian hideaway offers an array of specially tailored wellness programmes
By Ann Lee Published
-
Lecanemab: the Alzheimer’s drug that could herald a cure
Speed Read Treatment slowed memory decline by 27% over 18 months but there are concerns over safety
By Chas Newkey-Burden Published
-
Home Office worker accused of spiking mistress’s drink with abortion drug
Speed Read Darren Burke had failed to convince his girlfriend to terminate pregnancy
By The Week Staff Published
-
In hock to Moscow: exploring Germany’s woeful energy policy
Speed Read Don’t expect Berlin to wean itself off Russian gas any time soon
By The Week Staff Published
-
Were Covid restrictions dropped too soon?
Speed Read ‘Living with Covid’ is already proving problematic – just look at the travel chaos this week
By The Week Staff Last updated
-
Inclusive Britain: a new strategy for tackling racism in the UK
Speed Read Government has revealed action plan setting out 74 steps that ministers will take
By The Week Staff Published
-
Sandy Hook families vs. Remington: a small victory over the gunmakers
Speed Read Last week the families settled a lawsuit for $73m against the manufacturer
By The Week Staff Published
-
Farmers vs. walkers: the battle over ‘Britain’s green and pleasant land’
Speed Read Updated Countryside Code tells farmers: ‘be nice, say hello, share the space’
By The Week Staff Published
-
Motherhood: why are we putting it off?
Speed Read Stats show around 50% of women in England and Wales now don’t have children by 30
By The Week Staff Published